Literature DB >> 17567790

Development of real-time PCR assays for genotyping of Chlamydia trachomatis.

Hamid Jalal1, Hannah Stephen, Sarah Alexander, Christopher Carne, Christopher Sonnex.   

Abstract

We have developed and validated a nested real-time PCR (NRT-PCR) for the genotyping of Chlamydia trachomatis and used it specifically for the typing of either eight genovars from D to K or three genovars of lymphogranuloma venereum (LGV). The 11 probes used in the NRT-PCR correctly identified the DNA from D to K and LGV reference strains and did not cross-react with the DNA from 26 strains representing the bacterial pathogens and commensals of the oropharynx, genital tract, and rectum. The NRT-PCR had a 95% probability of detection at four genome copies (confidence interval, three to six copies) of C. trachomatis per reaction. One hundred cervical and urethral swab specimens containing C. trachomatis DNA from 63 women and 37 men were used to validate the method. The results from the NRT-PCR and the DNA sequencing of amplicons generated from the omp1 gene showed 100% correlation for these samples. The assay also identified the LGV-II genotype in 24 of 48 rectal swab specimens containing C. trachomatis DNA that were obtained from men having sex with men. The Sexually Transmitted Bacteria Reference Laboratory, London, independently confirmed these results using group-specific LGV real-time PCR and restriction fragment length polymorphism analysis. Compared with the NRT-PCR, non-NRT-PCR was found to be less sensitive: it typed C. trachomatis DNA in only 80% of the genital samples and 90% of the rectal swab samples. This is the first successful demonstration of the use of real-time PCR for the genotype-specific typing of C. trachomatis strains that cause sexually transmitted diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567790      PMCID: PMC1951269          DOI: 10.1128/JCM.00451-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Two-step polymerase chain reactions and restriction endonuclease analyses detect and differentiate ompA DNA of Chlamydia spp.

Authors:  B Kaltenboeck; K G Kousoulas; J Storz
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene.

Authors:  P Rodriguez; A Vekris; B de Barbeyrac; B Dutilh; J Bonnet; C Bebear
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

3.  Use of a reverse dot blot procedure to identify the presence of multiple serovars in Chlamydia trachomatis urogenital infection.

Authors:  D R Stothard
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Typing Chlamydia trachomatis by detection of restriction fragment length polymorphism in the gene encoding the major outer membrane protein.

Authors:  E H Frost; S Deslandes; S Veilleux; D Bourgaux-Ramoisy
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

Review 5.  Global data on blindness.

Authors:  B Thylefors; A D Négrel; R Pararajasegaram; K Y Dadzie
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

6.  Combination of PCR targeting the VD2 of omp1 and reverse line blot analysis for typing of urogenital Chlamydia trachomatis serovars in cervical scrape specimens.

Authors:  Monica Molano; Chris J L M Meijer; Servaas A Morré; Rene Pol; Adriaan J C van den Brule
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis.

Authors:  J Lan; J M Walboomers; R Roosendaal; G J van Doornum; D M MacLaren; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

8.  Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men.

Authors:  Rutger F Nieuwenhuis; Jacobus M Ossewaarde; Hannelore M Götz; Jan Dees; H Bing Thio; Maarten G J Thomeer; Jan C den Hollander; Martino H A Neumann; Willem I van der Meijden
Journal:  Clin Infect Dis       Date:  2004-09-08       Impact factor: 9.079

9.  Molecular epidemiology of genital human papillomavirus and Chlamydia trachomatis among patients attending a genitourinary medicine clinic - will vaccines protect?

Authors:  H Jalal; H Stephen; D F Bibby; C Sonnex; C A Carne
Journal:  Int J STD AIDS       Date:  2007-09       Impact factor: 1.359

10.  DNA sequence polymorphism of the Chlamydia trachomatis omp1 gene.

Authors:  C L Yang; I Maclean; R C Brunham
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

View more
  13 in total

1.  Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination.

Authors:  Matthew P Stevens; Jimmy Twin; Christopher K Fairley; Basil Donovan; Sarah E Tan; Jingxi Yu; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

2.  Rapid determination of lymphogranuloma venereum serovars of Chlamydia trachomatis by quantitative high-resolution melt analysis (HRMA).

Authors:  Jimmy Twin; Matthew P Stevens; Suzanne M Garland; Angelo M Zaia; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

3.  High prevalence of sexual infection by human papillomavirus and Chlamydia trachomatis in sexually-active women from a large city in the Amazon region of Brazil.

Authors:  Leonardo Miranda Dos Santos; Josiellem Damasceno de Souza; Hilary Acha Mbakwa; Akim Felipe Santos Nobre; Rodrigo Covre Vieira; Stephen Francis Ferrari; Anderson Raiol Rodrigues; Edna Aoba Yassui Ishikawa; João Farias Guerreiro; Maísa Silva de Sousa
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

4.  Genotyping of Chlamydia trachomatis by microsphere suspension array.

Authors:  Chung-Ter Huang; Wing-Wai Wong; Lan-Hui Li; Chien-Chou Chiang; Bor-Dong Chen; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

5.  Genotyping Chlamydia trachomatis strains among men who have sex with men from a Northern Spain region: a cohort study.

Authors:  P Mejuto; J A Boga; M Junquera; A Torreblanca; P S Leiva
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

6.  Evaluation of a high resolution genotyping method for Chlamydia trachomatis using routine clinical samples.

Authors:  Yibing Wang; Rachel J Skilton; Lesley T Cutcliffe; Emma Andrews; Ian N Clarke; Pete Marsh
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

7.  Chlamydia trachomatis genotypes and the Swedish new variant among urogenital Chlamydia trachomatis strains in Finland.

Authors:  Suvi Niemi; Eija Hiltunen-Back; Mirja Puolakkainen
Journal:  Infect Dis Obstet Gynecol       Date:  2011-05-18

8.  High Frequency of Chlamydia trachomatis Mixed Infections Detected by Microarray Assay in South American Samples.

Authors:  Lucía Gallo Vaulet; Carolina Entrocassi; Ana I Portu; Erica Castro; Susana Di Bartolomeo; Anke Ruettger; Konrad Sachse; Marcelo Rodriguez Fermepin
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

9.  High prevalence of sexual Chlamydia trachomatis infection in young women from Marajó Island, in the Brazilian Amazon.

Authors:  Leonardo Miranda Dos Santos; Maria Renata Mendonça Dos Santos Vieira; Jéssica Fernanda Galdino Oliveira; Josinaide Quaresma Trindade; Danielle Murici Brasiliense; Stephen Francis Ferrari; Mihoko Yamamoto Tsutsumi; Hellen Thais Fuzii; Edivaldo Costa Sousa Junior; Edna Aoba Yassui Ishikawa; Ricardo Ishak; Maísa Silva de Sousa
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

10.  Rapid detection of Chlamydia trachomatis and typing of the Lymphogranuloma venereum associated L-Serovars by TaqMan PCR.

Authors:  Anke Schaeffer; Birgit Henrich
Journal:  BMC Infect Dis       Date:  2008-04-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.